PRX-12251

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NamePRX-12251
Drug Alias Nametriple monoamine reuptake inhibitor (Prexa)serotonin/noradrenaline/dopamine reuptake inhibitors (Prexa Pharmaceuticals)PRX-12251
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNorepinephrine reuptake inhibitorsSerotonin reuptake inhibitors
TargetsNorepinephrine transporterSerotonin transporter
Therapy Area/IndicationsMental DisordersNervous System Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesPrexa Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPrexa Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsMental DisordersNervous System Diseases

Other Information

ATC CodeN/A
Related LinksN/A